This bill — known as the Right to Try Act — would allow the use of experimental treatments that haven’t been approved by the Food and Drug Administration (FDA) by terminally ill patients in accordance with state law. Patients would be required to provide written informed consent that they’re aware of possible risks.
No producer, manufacturer, distributor, prescriber, dispenser, possessor, or user of an experimental treatment could be held liable for providing the patient with the with the treatment. No outcome of the treatment could be used by a federal agency reviewing the treatment to delay or otherwise adversely impact the review or approval of the experimental treatment.
The bill’s full title is the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018.